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Abstract Glycosaminoglycan side chains of membrane proteo-
glycans have been claimed to be located at the outermost layer of
the glycocalyx surrounding the cell. In this study measurements
by surface plasmon resonance and solid-phase assay have shown
that both chondroitin sulfate and keratan sulfate but not heparin
associate with phosphatidylcholine under physiological condi-
tions. Spectrophotometric measurements also showed that
chondroitin sulfate restricts the lateral diffusion of phosphati-
dylcholine in liposomes. These findings indicate that chondroitin
sulfate and/or keratan sulfate chains of membrane proteoglycans
crouch on the surface of the membrane while heparan sulfate
chains stretch outward from the membrane surface as postulated
traditionally. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The elucidation of membrane organization is of prime im-
portance for the understanding of its functions. Increasingly
sophisticated membrane models have been proposed. In 1971,
the £uid mosaic model emphasized the autonomy and di¡u-
sional mobility of membrane lipids and proteins and the con-
sequent lack of lateral organization of the bilayer membrane
[1]. Subsequently, attention focused on the elucidation of the
asymmetrical organization of the membrane molecules and
the cell surface organization which determines a face of the
cell [2^4]. A number of experimental results indicate that the
outer lea£et of the membrane is a mixture of various lipid
molecules organized and segregated in microdomains,
although it is mainly composed of phosphatidylcholine (re-
viewed by Edidin and Jacobson et al. [5,6]). Recently func-
tional microdomains such as rafts in cell membranes were
proposed [7]. The carbohydrate coat of the cell named glyco-
calyx is composed of three kinds of glycoconjugates, that is,
glycolipids, glycoproteins and proteoglycans which can be lik-
ened to grasses, bushes and tall trees in reference to their
respective heights from the ground (cell surface).
Recently, special attention has been given to the role of
membrane-bound proteoglycans. They impose structural con-
straints, function as growth-supportive or -suppressive mole-
cules, possess adhesive and anti-adhesive properties, act as
major biological ¢lters, promote angiogenesis, induce neurite
outgrowth and deliver growth factors to target cells during
normal development and in pathological states (for reviews,
see [8,9]). A number of proteoglycans have been characterized,
based on the type of their glycosaminoglycan chains and their
location along the polypeptide backbone. The glycosamino-
glycan chains vary greatly in number and type depending on
the proteoglycans. In most membrane proteoglycans chon-
droitin sulfate and keratan sulfate chains uniquely attach to
the nearby cell surface, although the biological meanings are
unknown.
Most of the known proteoglycan binding molecules recog-
nize the glycosaminoglycan portions of the proteoglycans. On
the other hand, certain proteoglycans express C-type lectin
domain(s) by which they can combine with the carbohydrate
chains of other biological molecules (for review, see [8]).
Krumbiegel and Arnold [10] have found by microelectropho-
resis measurements with liposomes that heparin and its ho-
mologue, dextran sulfate, bind phosphatidylcholine, although
under non-physiological conditions. Using di¡erent assay sys-
tems, we demonstrate here that under physiological conditions
chondroitin sulfate and keratan sulfate, but not heparin, bind
phosphatidylcholine.
2. Materials and methods
2.1. Polymers
Heparin was purchased from Wako (Osaka, Japan; Lot ACP1104),
heparan sulfate (Lot S96301), chondroitin (Lot S95301), chondroitin
sulfate A (Lot S93401), chondroitin sulfate C (Lot S92Y06) and der-
matan sulfate were from Seikagaku (Tokyo, Japan). Chondroitin sul-
fate, a mixture of ca. 60% chondroitin sulfate A and ca. 40% chon-
droitin sulfate C, was prepared from bovine bronchial tubes by
previously reported methods [11]. Keratan sulfate was prepared
from shark ¢n according to the method previously reported [12].
Fucoidan (Lot 174H3862), dextran sulfate (Lot 26H0133) and poly-
galacturonic acid (Lot 115H3776) were from Sigma.
2.2. DAWN analysis
DAWN analysis, which is also called SEC-MALL (aqueous size
exclusion chromatography and multiangle laser light scattering), was
performed according to the method reported by Nagy [13]. The size
exclusion chromatography consisted of a Shodex size exclusion col-
umn Protein KW-803, Shodex RI-71 refractive index detector (Showa
Denko, Tokyo, Japan) and a Wyatt Technology Model MINI
DAWN multiangle laser light scattering photometer (Wyatt, Santa
Barbara, CA, USA) and was operated at room temperature with a
£ow rate of 1.0 ml/min. Molecular weights were calculated using
ASTRA software from Wyatt Technology. Speci¢c refractive index
increment values (dn/dc) were used, in the case of protein 0.180 ml/g,
in the case of glycosaminoglycan 0.129 ml/g.
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2.3. Biacore analysis
Dimyristoylphosphatidylcholine (PC), phosphatidylethanolamine
(PE, egg yolk), phosphatidylserine (PS, bovine brain) and phosphati-
dylinositol (PI, bovine liver) were from Sigma. Liposomes composed
of PC alone and PS/PC, PE/PC and PI/PC in a ratio of 1:1 were
prepared by sonication and ¢ltration. The hydrophobic chip HPA
was initially washed with 0.1 mM L-octyl-D-glucoside for 5 min at a
£ow rate of 5 Wl/min. Liposomes in 10 mM HEPES-bu¡ered saline
(pH 7.4) (HBS) were then injected for 30 min at a £ow rate of
1 Wl/min. An increase of the £ow rate to 5 Wl/min as well as a brief
injection of 10 mM NaOH was su⁄cient to wash o¡ the unbound
phospholipids and to plane the phospholipid surfaces. The chip had
phospholipid mixtures immobilized (ca. 2000 RU). 40 Wl of glycosa-
minoglycan solution in HBS was then injected in the presence of 1 mM
calcium ion at a £ow rate of 20 Wl/min. The chip was regenerated after
each cycle of measurements by injecting 10 Wl of 0.5 M EDTA. The
kinetic parameters were calculated by the evaluation program BIA-
evaluation 3.0.
2.4. Binding assay of PC and chondroitin sulfate using ELISA plates
Oxidation of chondroitin sulfate was performed at room temper-
ature in 0.1 M sodium acetate (pH 5.5) containing 3.3 mM sodium
metaperiodate in the dark. After 1 h incubation, the oxidation was
stopped by adding an excess of sodium sul¢te. The chondroitin sulfate
was further incubated with biotin-hydrazide (Pierce) at a ¢nal concen-
tration of 0.3 mg/ml. The excess biotin was then removed on an NAP-
5 column (Pharmacia). Phospholipid-coated ELISA plates were used.
50 Wl of 1 mg/ml of phospholipids in ethanol was added to the well of
the ELISA plate, and then allowed to stand for 18 h at 37‡C. The
phospholipid-coated well was washed with HBS and blocked with 1%
bovine serum albumin for 1 h, and then 50 Wl of biotin-labeled chon-
droitin sulfate was added in the presence of 1 mM CaCl2. The well
was washed and then, 50 Wl of diluted horseradish peroxidase-conju-
gated biotin streptavidin complex (Amersham) with HBS at a ¢nal
dilution of 1:500 was added to each well and allowed to stand for
30 min. After incubation with horseradish peroxidase conjugates, the
wells were washed and developed.
2.5. Fluorescence measurements
Fluorescence measurements [13] were performed on a spectro£uo-
rometer (Hitachi) with excitation at 340 nm and emission typically
scanned between 350 and 480 nm. Samples were prepared as 1.5 ml
total volume in 10 mM HEPES-bu¡ered saline containing 1 mM
CaCl2 at pH 7.4. Vesicles were used at 0.42 mM total lipid.
3. Results and discussion
Table 1 summarizes the physicochemical and PC binding
properties of the glycosaminoglycans and other acidic poly-
saccharides employed in this study. Chondroitin sulfate and
keratan sulfate, but not heparin and heparan sulfate, were
found to bind to PC monolayer. A sensorgram (Biacore pro-
¢le) of the interaction of chondroitin sulfate with PC immo-
bilized on a sensor chip, which is dose-dependent, is shown in
Fig. 1. The addition of other phospholipids, such as PS, PE
and PI, to PC decreased the bindings in all cases, indicating
that chondroitin sulfate speci¢cally binds to PC and not to
other phospholipids. No correlation was found between the
sulfate content (Table 1) of chondroitin sulfate and its ability
to combine with PC, indicating that binding does not seem to
be due to ionic interactions between positive charges of the
PC head groups and negative charges of the glycosaminogly-
can. The fact that the interaction increases with temperature
(Fig. 2) suggests that it is hydrophobic and not ionic. Solid
phase binding assays were also performed using ELISA plates.
Biotinylated chondroitin sulfate bound to immobilized PC
and the binding was inhibited with free unlabeled chondroitin
sulfate (Fig. 3) but not with heparin, con¢rming that the
Table 1
Phosphatidylcholine binding properties of glycosaminoglycans
Glycosaminoglycan MWa (U103) Sulfate content (%) Amino sugar Uronic acid Sulfation Boundb (RU)
Heparin 13.2 30 GlcN GlcUA O- 0.0
IdoUA N-
Heparan sulfate 6.7 9 GlcN GlcUA O- 0.2
IdoUA N-
Keratan sulfate 14.9 15 GlcN Gal O- 27.1
Chondroitin sulfate 8.7 18 GalN GlcUA O- 5.4
Chondroitin sulfate A 17.2 18 GalN GlcUA O- 0.0
Chondroitin sulfate C 26.4 18 GalN GLcUA O- 4.2
Chondroitin 8.9 3 GalN GlcUA ^ 0.0
Dermatan sulfate 18.9 21 GalN GlcUA O- 0.0
IdoUA
Fucoidan 91.2 25 Fuc O- 29.0
Dextran sulfate 69.7 51 Glc O- 0.0
Polygalacturonic acid N.D. 0 GalUA ^ 20.1
GlcN: N-acetyl-D-glucosamine; GalN: N-acetyl-D-galactosamine; GlcUA: D-glucuronic acid; IdoUA: L-iduronic acid; Gal: D-galactose; Fuc:
L-fucose; Glc: D-glucose; GalUA: D-galacturonic acid; RU: relative resonance units; glycosaminoglycan concentration = 0.1 mg/ml, at 25‡C;
N.D.: not determined.
aMolecular weights were established by DAWN analysis.
bBound was obtained by Biacore analysis.
Fig. 1. Sensorgram of chondroitin sulfate binding to immobilized
PC. The y-axis presents the amount of bound glycosaminoglycan as
relative response (resonance units (RU)) and the x-axis presented
time (in seconds). Various concentrations of chondroitin sulfate so-
lution were £owed over the immobilized PC on HPA sensor chips
at a £ow rate of 20 Wl/min in the presence of 1 mM calcium ion at
25‡C.
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interaction is speci¢c. Keratan sulfate and chondroitin sulfate
interactions with PC have a similar vG (Table 2).
The aggregation of PC by chondroitin sulfate was con-
¢rmed by measurement of lipid dynamics in vesicles contain-
ing phosphatidylglycerol, pyrene-labelled phosphatidylglycer-
ol and PC. Changes in the lipid dynamics of the vesicles were
successfully monitored by measuring the red shift of the £uo-
rescence induced upon formation of pyrene dimers (excimer).
The £uorescence of pyrene-phosphatidylglycerol monomer
was integrated between 394 and 420 nm, while excimer emis-
sion was integrated between 474 and 482 or 470 and 490 nm.
When chondroitin sulfate was allowed to react with phospha-
tidylglycerol/PC lipid membranes, the level of pyrene dimer
was dramatically increased as shown in Fig. 4. The results
indicate that chondroitin sulfate segregates the PC molecules,
restricts their lateral mobility and forms the phosphatidylgly-
cerol-rich domain where the formation of pyrene dimers is
induced.
In the course of our study, a sulfated fucose polymer, fu-
coidan, which is not a member of mammalian glycosamino-
glycans, was also found to bind to PC. This polysaccharide is
of interest since it was found to possess antiproliferative and
antitumor properties, to inhibit tumor metastasis [14^16], and
to induce apoptosis in HL-60 cells (our unpublished results).
These properties have been ascribed to the interference by
fucoidan of the passage of the tumor cells through the capil-
lary wall by the sulfate groups on the polysaccharides. Our
results lead us to propose that the formation of PC micro-
domains by glycosaminoglycan binding to OC may be in-
volved in this phenomenon. The exposure of other microdo-
mains such as PS microdomains induced by the formation of
PC microdomains on the tumor cells may cause apoptosis.
Our model proposed in Fig. 5 implies that chondroitin sul-
fate and keratan sulfate are like vines on the ground rather
than the crown of a tall tree and contribute to the formation
of PC microdomains in the outer lea£et of the cell membrane.
Hakomori and coworkers have reported that glycosphingo-
lipids consisting of ceramide and carbohydrate residues form
Fig. 2. E¡ect of temperature on binding of glycosaminoglycan to
PC. The y-axis presents relative amounts of binding (Bound, in
RU). 1 mg/ml of chondroitin sulfate or keratan sulfate solution was
£owed over the immobilized PC on HPA sensor chips at a £ow rate
of 20 Wl/min in the presence of 1 mM calcium ion at 25‡C or 37‡C.
Fig. 3. Interaction between chondroitin sulfate and PC and its inhi-
bition assayed by ELISA. The y-axis presents relative amount of
bound chondroitin sulfate as absorbance at 490 nm by color devel-
opment of horseradish peroxidase. Chondroitin sulfate bound to im-
mobilized PC on ELISA plate in a dose-dependent manner (A). The
binding of chondroitin sulfate to PC was inhibited by the addition
of unlabeled chondroitin sulfate (B).
Fig. 4. Measurement of lipid dynamics in vesicles by pyrene £uores-
cence. Changes in the dynamics of lipid molecule phosphatidylgly-
cerol/PC vesicles were detected using the £uorescence of a phospha-
tidylglycerol derivative containing pyrene in one acyl chain (pyrene-
phosphatidylglycerol, Molecular Probes). The measurement of
monomer (M) and excimer (E) emissions is proportional to the re-
spective total emissions; also the calculated percent changes in E/M,
[(E/M)¢nal3(E/M)initial]/(E/M)initialU100%, are accurate since the
proportionalities cancel out. The percent change in E/M was su⁄-
cient for analyzing the changes in pyrene-PC dynamics to measure
lateral di¡usion of phospholipids in vesicles [16]. The ¢gure shows
percent change in monomer and excimer £uorescence intensities be-
tween scans of pyrene-phosphatidylglycerol/PC vesicles. Data re£ect
the average of three determinations.
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microdomains as structural and functional units and some of
the signal transductions are assumed to be directly induced
through microdomains of glycosphingolipids (reviewed by
Hakomori et al. [17]). In this case, glycosphingolipids seem
to associate laterally with one another through weak interac-
tions among the carbohydrate heads of the lipids. With a
di¡erent approach, Jacobson et al. found that glycosphingo-
lipids preferentially associate with glycosyl-phosphatidyl-ino-
sitol-anchored proteins, such as Thy-1 [18,19]. Although gly-
cosaminoglycans of membrane proteoglycan have been
assumed to cover most of the outer surface of the cell includ-
ing the membrane glycolipids, the chondroitin sulfate/keratan
sulfate^PC microdomains proposed in this study may not only
contribute to strengthening the membrane structure but also
to the e⁄cient exposure on the cell surface of glycolipid mi-
crodomains or other domains such as PS-rich ones.
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Table 2
Kinetic constants of the interaction of glycosaminoglycans with PC at 37‡C
Glycosaminoglycan Kd (nM) kd (s31) ka (M31 s31) vG (kJ mol31)a
Keratan sulfate 6.3U1038 2.0U1034 3.2U103 343
Chondroitin sulfate 1.0U1037 1.5U1034 1.5U103 341
aln(1/Kd) =3vG/RT (R = 8.31 JK mol31, T = 298 K or 310 K).
Fig. 5. Proposed model of organization of PC and glycosaminogly-
can in the plasma membrane. Clusters of PC (dark blue) and glyco-
sphingolipids (red, with yellow oligosaccharides) are present on the
outer lea£et of the plasma membrane. Other membrane lipids are
light blue. Protein cores of glycoproteins and proteoglycans and N-
linked oligosaccharides on glycoproteins are magenta. Chondroitin
sulfate and keratan sulfate chains are violet. Heparan sulfate chains
are green.
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